The company will use the financing to support clinical trials focusing on Parkinson’s, amyotrophic lateral sclerosis and schizophrenia.
The expansion brings the company’s total series B financing round to $116 million, according to a Feb. 13 Cerevance news release provided to Becker’s.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
